These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8252414)

  • 1. Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions.
    Rowland NE; Kalehua AN; Li BH; Semple-Rowland SL; Streit WJ
    Brain Res; 1993 Oct; 624(1-2):35-43. PubMed ID: 8252414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography.
    Appel NM; Mitchell WM; Contrera JF; De Souza EB
    Synapse; 1990; 6(1):33-44. PubMed ID: 2144664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulations of synaptic serotonin: discrepancy of effects on serotonin S1 and S2 sites.
    Dumbrille-Ross A; Tang SW
    Life Sci; 1983 Jun; 32(23):2677-84. PubMed ID: 6602261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dexfenfluramine on alcohol intake in alcohol-preferring "P" rats.
    Rowland NE; Morian KR
    Alcohol; 1992; 9(6):559-61. PubMed ID: 1472314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic d-fenfluramine treatment reduces fat intake independent of macronutrient preference.
    Smith BK; York DA; Bray GA
    Pharmacol Biochem Behav; 1998 May; 60(1):105-14. PubMed ID: 9610931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons.
    Kalia M
    Brain Res; 1991 May; 548(1-2):111-25. PubMed ID: 1868326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenalectomy enhances the anorectic effect of dexfenfluramine: relation to mineralocorticoids and salt appetite.
    Rowland NE; Dotson LM
    Physiol Behav; 1993 Aug; 54(2):203-6. PubMed ID: 8372110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to the anorectic effect of dexfenfluramine in rats: role of serotonin, cholecystokinin, and neuropeptide Y.
    Rowland NE
    Physiol Behav; 1994 Feb; 55(2):201-7. PubMed ID: 8153156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of short- and long-term effects of DL-fenfluramine on the serotonergic innervation of the rat hippocampal formation.
    Sotelo C
    Brain Res; 1991 Feb; 541(2):309-26. PubMed ID: 2054644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of dexfenfluramine-induced anorexia and c-Fos/c-Jun expression by lesion in the lateral parabrachial nucleus.
    Li BH; Spector AC; Rowland NE
    Brain Res; 1994 Mar; 640(1-2):255-67. PubMed ID: 8004454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does GFAP mRNA and mitochondrial benzodiazepine receptor binding detect serotonergic neuronal degeneration in rat?
    Bendotti C; Baldessari S; Pende M; Tarizzo G; Miari A; Presti ML; Mennini T; Samanin R
    Brain Res Bull; 1994; 34(4):389-94. PubMed ID: 8082031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term administration of dexfenfluramine to genetically obese (ob/ob) and lean mice: body weight and brain serotonin changes.
    Rowland NE
    Pharmacol Biochem Behav; 1994 Oct; 49(2):287-94. PubMed ID: 7824540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of dexfenfluramine in pregnant rats: effect on brain serotonin parameters in offspring.
    Rowland NE; Robertson RM
    Pharmacol Biochem Behav; 1992 Aug; 42(4):855-8. PubMed ID: 1513868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
    Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy.
    Bergqvist PB; Hjorth S; Wikell C; Apelqvist G; Bengtsson F
    Metab Brain Dis; 1997 Sep; 12(3):229-36. PubMed ID: 9346471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NMDA receptor antagonist MK-801 does not protect against serotonin depletions caused by high doses of DL-fenfluramine.
    Sabol KE; Richards JB; Seiden LS
    Brain Res; 1992 Jun; 582(1):129-33. PubMed ID: 1386771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial response to degeneration of serotonergic axon terminals.
    Wilson MA; Molliver ME
    Glia; 1994 May; 11(1):18-34. PubMed ID: 8070892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
    Xie T; Tong L; McLane MW; Hatzidimitriou G; Yuan J; McCann U; Ricaurte G
    Neuropsychopharmacology; 2006 Dec; 31(12):2639-51. PubMed ID: 16452989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.